Elsevier and Medical Education Technologies, Inc. Collaborate to Offer Simulation Technology for Health Science Curriculums
Partnership fully integrates nursing education content and solutions with human patient simulators
St. Louis, MO – 23 May, 2011 – Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today a partnership agreement with Medical Education Technologies, Inc. (METI), a leading manufacturer of medical simulation and health care learning technologies. The companies will collaborate to release a turn-key health care education product that combines Elsevier’s nursing education content with METI’s human patient simulators.
“Nursing programs around the country are looking for more effective ways to prepare the future health care workforce for success in the realities of clinical practice,” said Tom Wilhelm, Vice President, e-solutions, Elsevier Nursing and Health Professions. “This new solution will provide nursing students with hands-on learning when clinical space is at a premium, and offer the training and experience they need to handle new and emerging best practices and technologies. For educators, this product provides a solution that enables them to deliver simulated clinical experiences without having to manually change each setting in the patient simulator.”
Elsevier and METI will combine METI’s human patient simulators integrated with Müse®, a medical trainer’s simulator operating software, with Elsevier’s current suite of nursing simulation products, including Sim Chart, a new simulated EHR and charting system, and Simulation Learning System (SLS), an online toolkit that helps instructors and facilitators effectively standardize and incorporate medium to high fidelity simulation into their nursing curriculum.
“Elsevier and METI’s new offering is a seamless solution that will make it much easier for us to integrate simulation activities into our nursing program and provide more comprehensive training for future nurses,” said Kim Leighton, Dean of Educational Technology, BryanLGH College of Health Sciences. “The new product will allow us to spend more time preparing our students for real-life clinical situations they will face in the workplace, and less time preparing our simulation activities.”
The combined solution is available to nursing education programs and schools through Elsevier or METI. Customers who have already purchased a METI human patient simulator can integrate the Elsevier content for the complete solution. Elsevier will also continue to offer its education content without METI simulators, and METI simulators are available without Elsevier content. More information can be found at http://www.elsevieradvantage.com/simulations/ or http://www.meti.com/products_lm_pnci.htm.
“This partnership comes at a crucial time because of the current shortage of clinical sites for nursing and health professional education,” said Michael Bernstein, President and CEO of METI. “In addition, incentives in the government’s recent health care legislation are driving increased adoption of simulation technology. Elsevier is highly regarded in nursing education and shares our vision and commitment to provide technology that supports the direction health care is going and the advancement of real-world training that improves patient safety and ultimately, saves lives.”
# # #
Based in Sarasota, Florida, METI has been a leader in interactive human patient simulation since 1996. The entire family of METI simulators, including baby, pediatric and adults, are designed to mimic human medical scenarios including trauma, heart attack, drug overdose and effects of bioterrorism. Today, more than 7,000 METI simulators are in use worldwide by defense organizations, medical schools, nursing schools, hospitals and other entities involved in healthcare education. METI is privately owned by Lou Oberndorf and Baird Capital Partners (BCP) of Chicago.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Vice President, Global Corporate Relations
+1 215 239 3508